key: cord-1013720-li5gjtw4
authors: Barsoum, Zakaria
title: CORONAVIRUS (COVID‐19) PANDEMIC: PERSONAL VIEW TO A NEW MODEL OF PAEDIATRIC PRACTICE
date: 2020-06-22
journal: J Paediatr Child Health
DOI: 10.1111/jpc.14958
sha: 338fc4e668c244be6f8cb7e9649650233765e998
doc_id: 1013720
cord_uid: li5gjtw4

nan

Coronavirus (COVID-19) pandemic is an unprecedented challenge to health-care professionals. Central in its management remain social distancing, personal hygiene and wearing proper personal protective equipments. Distant medical practising is alien to clinicians. Virtual consultations deploying recent technology have now replaced the normal practice of routine clinics.

Virtual consultations minimise the risk of COVID-19 transmission, promote public protection and reduce the backlog of waiting lists during this time of testing.

Many clinicians may feel uncomfortable with this new model of practice where the gold standard rule in medical practice is direct contact with patients. Face to face consultations help build up rapport between doctors and patients. Face to face clinical practice enables clinicians to better identify clinical problems and provide meticulous clinical assessment. Uplifting patient safety and sound clinical judgement are a top priority for physicians.

Virtual clinics are useful tools at the time of COVID-19 pandemic when health-care demands are pressing. Clinicians are at the front door in this battle and subsequently are at increased risks of contracting disease and transmitting it to their close contacts and loved ones, placing physicians under immense emotional pressures.

Children with allergy, such as food allergy, are a special cohort that may benefit well from virtual consultations. The preponderance of them are well and parents can provide a detailed allergy focused clinical history guided by clinicians during virtual consultations. The quality of video recording can provide clues about various allergic skin manifestations. Obtaining allergy focused clinical history is a quality statement (The National Institute for Health and Care Excellence report -March 2016).

In our unit, paediatric allergy team had forethought to launch virtual clinics before recent recommendations from The British Society for Allergy and Clinical Immunology (BSACI) justified this model (BSACI report, on 24 March 2020). Service started on 23 March 2020, eight clinics were run and 50 patients reviewed. No adverse events were reported and patient perception of the new service was encouraging.

Adjustments were made related to specific allergy investigations such as skin prick tests, congruent with BSACI recommendations, those tests can be deferred during COVID-19 pandemic. 1 In brief, virtual clinics are useful at times of pandemics although they lack direct clinical relationship with patients.

Virtual consultations deploy recent technology in medicine and are recommended by professional bodies. Although clinical confidence and appropriateness of use may vary in various aspects of clinical care, our experience in paediatric allergy is satisfactory. Dear Editor,

Paediatricians are increasingly confronted with complex challenges such as the diagnosis of incurable illness and the limitations posed by medicine itself. Even the definition of incurable illness can frequently be problematic; as time passes the prognosis can change, not only because of the child's evolving maturity and the unpredictable trajectory of the illness but also due to therapeutic innovations. But the distinction between incurability and potential curability may become fuzzy, with inevitable consequences to the child's existence and quality of life. The problem is relevant when dealing with rare diseases where the severity of the illness and the consequential risks to life justify a fervent quest for effective solutions. However, at the same time, it must be acknowledged how the burden of the proposed treatments can condition their effectiveness and negatively impact the child and family's quality of life.

Spinal muscular atrophy can be considered a paradigm: the availability of a recently approved drug has radically changed the course of the illness by offering patients an enhanced duration and quality of life. However, if this ground-breaking treatment is initiated late in the course of the disease, it does not significantly improve their clinical situation. On the contrary, the anxiety and distress caused by the prospect of being subjected to a burdensome lifelong procedure (it is administered every 4 months via spinal canal injection), linked to the frustration, triggered by disappointing results or the lack of improvement, can significantly impact the child and family's quality of life. Furthermore, the cost of the drug and of the hospital admissions must also be added to the balance. 1, 2 Therefore, when evaluating the introduction of new treatments, as opposed to applying standardised protocols, we should always aim to adopt a flexible approach that takes into consideration each individual patient's global needs. We currently care

Whitish cystic lesion over the scrotum and penis

Congenital multiple median raphe cysts of the penis and scrotum